GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lifecome Biochemistry Co Ltd (SZSE:002868) » Definitions » Asset Impairment Charge

Lifecome Biochemistry Co (SZSE:002868) Asset Impairment Charge : ¥0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Lifecome Biochemistry Co Asset Impairment Charge?

Lifecome Biochemistry Co's Asset Impairment Charge for the three months ended in Mar. 2024 was ¥0.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.0 Mil.


Lifecome Biochemistry Co Asset Impairment Charge Historical Data

The historical data trend for Lifecome Biochemistry Co's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifecome Biochemistry Co Asset Impairment Charge Chart

Lifecome Biochemistry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Lifecome Biochemistry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Lifecome Biochemistry Co Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.


Lifecome Biochemistry Co Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Lifecome Biochemistry Co's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifecome Biochemistry Co (SZSE:002868) Business Description

Traded in Other Exchanges
N/A
Address
No.19, Nanpu Ecological Industrial Park, Pucheng, Fujian, CHN, 353400
Lifecome Biochemistry Co Ltd is a biopharmaceutical company which is engaged in the microbial pharmacy in China. Its main products include Bacitracin Zinc products (Bacitracin Zinc Premix, Bacitracin Zinc API), Colistin Sulfate products (Colistin Sulfate Premix, Colistin Sulfate API), Probiotics products (Bacillus Subtilis, Bacillus Licheniformis), Bacitracin Methylene Disalicylate products, biological preservatives: and Natamycin products.

Lifecome Biochemistry Co (SZSE:002868) Headlines

No Headlines